2，Wyseenbeek AJ,Leibovici L,Amit M,et al.Alopecia in systemic l upus erythematosus:relation to diseases manifestations.J Rheuma-tol,1991,18:118 5-1186.
3，Foote RA,Kimbrough SM,Stevens JC.Lupus myositis.Muscle Ne-rv e,1982,5:65-68.
4，Lavras-Costallat LT,Valente-Coimbra AM.Raynaud′s phenomeno n in systemic lupus erythematosus.Rev Rhum Engl Ed,1995,62:349-353.
5，Hashimoto H,Tsuda H,Hirano T,et al,Differences in clinical an d immunological findings of systemic lupus erythematosus related to age.J Rheuma tol,1987,14:497-501.
6，Cervera R,Khamashta MA,Font J,et al.Systemic lupus erythemato sus:clinical and immunologic patterns of disease expression in a cohort of 1 000 patients.Medicine,1993,72:113-124.
7，Dimant J,Ginzler MS,Sterba G,et al.The clinical significance of Raynaud′s phenomenon in systemic lupus erythematosus.Arthritis Rheum,1979,22 :815-819.
8，初洁秋，李春雯，高滨昌.雷诺征对结缔组织病的临床意义.中国中 西医结合风湿病杂志，1998，7：113-114.
9，Pistiner M,Wallace DJ,Nessim S,et al.Lupus erythematosus in t he 1980s:a survey of 570 patients.Semi Arthritis Rheum,1991,21,55-64.
10，Rothfield NF.Systemic lupus erythematosus:clinical and laboratory asp ects.In:McCarthy DJ,eds.Arthritis and allied condition.3rd ed.Philadelphia:Lea and Fiebiger,1989.1022-1047.
11，Bunker CB,Goldsmith PC,Leslie TA,et al.Calcitonin gene-related pepti de,endothelin-1,the cutaneous microvasculature and Raynaud′s phenomenon.Br J D ermatol,1996,134:399-406.
12，Salazar PM,de la Garcia-Torre I,Fritzler MJ,et al.Antibodies to fibr in -bound tissue-type plasminogen activator in systemic lupus erythematosus ar e associated with Raynaud′s phenomenon and thrombosis.Lupus,1996,5:275-278.
上一页 1 2 [3] 4 下一页
